{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportid": "4931032-2",
      "transmissiondateformat": "102",
      "transmissiondate": "20060701",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20060227",
      "receiptdateformat": "102",
      "receiptdate": "20060215",
      "fulfillexpeditecriteria": "1",
      "companynumb": "200610901BWH",
      "primarysource": {
        "reportercountry": "UNITED STATES"
      },
      "sender": {
        "senderorganization": "FDA-Public Use"
      },
      "receiver": null,
      "patient": {
        "patientonsetage": "65",
        "patientonsetageunit": "801",
        "patientweight": "50",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddrapt": "DISEASE PROGRESSION"
          },
          {
            "reactionmeddrapt": "DYSPNOEA"
          },
          {
            "reactionmeddrapt": "FATIGUE"
          },
          {
            "reactionmeddrapt": "GINGIVAL BLEEDING"
          },
          {
            "reactionmeddrapt": "METASTASES TO CENTRAL NERVOUS SYSTEM"
          },
          {
            "reactionmeddrapt": "OSTEONECROSIS"
          },
          {
            "reactionmeddrapt": "PERIODONTAL DISEASE"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "SORAFENIB",
            "drugauthorizationnumb": "21923",
            "drugdosagetext": "400 MG BID ORAL",
            "drugadministrationroute": "048",
            "drugindication": "NON-SMALL CELL LUNG CANCER",
            "drugstartdateformat": "102",
            "drugstartdate": "20041116",
            "drugenddateformat": "102",
            "drugenddate": "20050111",
            "openfda": {
              "application_number": [
                "NDA021923",
                "ANDA209050",
                "ANDA209567",
                "ANDA207012",
                "ANDA216073",
                "ANDA217095"
              ],
              "brand_name": [
                "NEXAVAR",
                "SORAFENIB",
                "SORAFENIB TOSYLATE"
              ],
              "generic_name": [
                "SORAFENIB"
              ],
              "manufacturer_name": [
                "Bayer HealthCare Pharmaceuticals Inc.",
                "Yabao Pharmaceutical Co., Ltd. Beijing",
                "Teva Pharmaceuticals, Inc.",
                "Upsher-Smith Laboratories, LLC",
                "Mylan Pharmaceuticals Inc.",
                "Dr.Reddys Laboratories Inc",
                "Torrent Pharmaceuticals Limited"
              ],
              "product_ndc": [
                "50419-488",
                "50419-489",
                "51990-201",
                "0480-5425",
                "24979-715",
                "0378-1201",
                "43598-458",
                "13668-682"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "SORAFENIB",
                "SORAFENIB TOSYLATE"
              ],
              "rxcui": [
                "597747",
                "615979"
              ],
              "spl_id": [
                "e597a26e-e04a-4f91-8c7c-a83243286396",
                "533bf507-3ac8-7c25-e063-6294a90a7ff2",
                "5f4a23bc-d026-46f0-b028-d92130032dc0",
                "55afb5e2-d3ae-6c46-e063-6394a90adec2",
                "40e1cce8-b7c1-4fad-8600-7d7b409bde7e",
                "b89d7cf3-c673-51c1-7ceb-9ce1cc1ad925",
                "27389dc4-60cc-4c65-92e6-97bcc09f7d20"
              ],
              "spl_set_id": [
                "b50667e4-5ebc-4968-a646-d605058dbef0",
                "06f442d6-071e-4081-b7f7-40f3b803ab3f",
                "dae598f7-823f-405c-ae31-f924594187b9",
                "68aa4b7f-3f13-4e73-b572-aa6c11a8429c",
                "b7919013-1511-44f0-a759-3fa78a9fa178",
                "93f9c3b2-d4c5-80d3-5421-8b4c29fbf8a6",
                "b5305e23-7bc6-44d8-b177-930c47d1653a"
              ],
              "package_ndc": [
                "50419-488-58",
                "50419-489-01",
                "51990-201-06",
                "51990-201-12",
                "0480-5425-89",
                "24979-715-44",
                "24979-715-04",
                "0378-1201-78",
                "43598-458-04",
                "43598-458-36",
                "13668-682-30",
                "13668-682-60",
                "13668-682-12",
                "13668-682-74"
              ],
              "nui": [
                "N0000175605",
                "N0000175076"
              ],
              "pharm_class_epc": [
                "Kinase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Protein Kinase Inhibitors [MoA]"
              ],
              "unii": [
                "9ZOQ3TZI87",
                "5T62Q3B36J"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ZOMETA"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "COLACE",
            "openfda": {
              "application_number": [
                "M007"
              ],
              "brand_name": [
                "COLACE"
              ],
              "generic_name": [
                "DOCUSATE SODIUM"
              ],
              "manufacturer_name": [
                "Atlantis Consumer Healthcare, Inc."
              ],
              "product_ndc": [
                "67618-101",
                "67618-111"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DOCUSATE SODIUM"
              ],
              "rxcui": [
                "1115005",
                "1247756",
                "1247759",
                "1247761"
              ],
              "spl_id": [
                "650714ee-2cec-42c9-8631-b3f8ebc7348f",
                "ec10da1a-de65-47d1-ae30-07ad97469e73"
              ],
              "spl_set_id": [
                "7793fced-e8ee-44e2-b212-dd2a59a5f462",
                "a1591da0-a1a9-9583-3cf5-788b8fee3814"
              ],
              "package_ndc": [
                "67618-101-10",
                "67618-101-30",
                "67618-101-60",
                "67618-101-01",
                "67618-101-52",
                "67618-101-51",
                "67618-101-25",
                "67618-111-28",
                "67618-111-42",
                "67618-111-60",
                "67618-111-10"
              ],
              "unii": [
                "F05Q2T2JA0"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "COMBIVENT"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DIOVAN",
            "openfda": {
              "application_number": [
                "NDA021283"
              ],
              "brand_name": [
                "DIOVAN"
              ],
              "generic_name": [
                "VALSARTAN"
              ],
              "manufacturer_name": [
                "Novartis Pharmaceuticals Corporation"
              ],
              "product_ndc": [
                "0078-0358",
                "0078-0423",
                "0078-1245",
                "0078-0359",
                "0078-1252",
                "0078-0360",
                "0078-1259"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "VALSARTAN"
              ],
              "rxcui": [
                "349199",
                "349200",
                "349201",
                "349483",
                "351761",
                "351762",
                "352001",
                "352274"
              ],
              "spl_id": [
                "8b57e357-5cfb-49a6-a600-59ce118fd1e9"
              ],
              "spl_set_id": [
                "5ddba454-f3e6-43c2-a7a6-58365d297213"
              ],
              "package_ndc": [
                "0078-0423-15",
                "0078-0358-34",
                "0078-1245-34",
                "0078-0359-34",
                "0078-1252-34",
                "0078-0360-34",
                "0078-1259-34"
              ],
              "nui": [
                "N0000000070",
                "N0000175561"
              ],
              "pharm_class_moa": [
                "Angiotensin 2 Receptor Antagonists [MoA]"
              ],
              "pharm_class_epc": [
                "Angiotensin 2 Receptor Blocker [EPC]"
              ],
              "unii": [
                "80M03YXJ7I"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FLOVENT",
            "openfda": {}
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MARINOL",
            "openfda": {
              "application_number": [
                "NDA018651"
              ],
              "brand_name": [
                "MARINOL"
              ],
              "generic_name": [
                "DRONABINOL"
              ],
              "manufacturer_name": [
                "ThePharmaNetwork, LLC"
              ],
              "product_ndc": [
                "53097-568",
                "53097-569",
                "53097-570",
                "53097-571",
                "53097-572",
                "53097-573"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DRONABINOL"
              ],
              "rxcui": [
                "197634",
                "197635",
                "197636",
                "205641",
                "205642",
                "205645"
              ],
              "spl_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48"
              ],
              "spl_set_id": [
                "628f9609-6583-49be-be77-b64cfbc46fd7",
                "d0efeeec-640d-43c3-8f0a-d31324a11c68"
              ],
              "package_ndc": [
                "53097-568-60",
                "53097-569-60",
                "53097-570-60",
                "53097-571-60",
                "53097-572-60",
                "53097-573-60"
              ],
              "nui": [
                "N0000175782",
                "M0003267"
              ],
              "pharm_class_epc": [
                "Cannabinoid [EPC]"
              ],
              "pharm_class_cs": [
                "Cannabinoids [CS]"
              ],
              "unii": [
                "7J8897W37S"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "OXANDRIN"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PLENDIL"
          }
        ]
      }
    }
  ]
}